Cargando…
Innovation and Precision Medicine Applied to a Medullary Thyroid Cancer: A Clinical Case
Medullary thyroid carcinoma (MTC) is a rare type of neuroendocrine tumor, accounting for 3%-4% of all thyroid cancers. Seventy-five percent are sporadic, of which 60% have pathogenic REarranged during Transfection (RET) somatic mutations. The sporadic RET-mutated MTC poses novel challenges for targe...
Autores principales: | Guedes, Helena, Leão, Inês, Soares, Adriana, Basto, Raquel, Joaquim, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329139/ https://www.ncbi.nlm.nih.gov/pubmed/37425604 http://dx.doi.org/10.7759/cureus.40107 |
Ejemplares similares
-
Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine
por: Matrone, Antonio, et al.
Publicado: (2022) -
Precision Medicine in Lymphoma by Innovative Instrumental Platforms
por: Di Paolo, Antonello, et al.
Publicado: (2019) -
Design of new drugs for medullary thyroid carcinoma
por: Li, Yanqing, et al.
Publicado: (2022) -
Targeted Therapy for Medullary Thyroid Cancer: A Review
por: Priya, S. R., et al.
Publicado: (2017) -
Nomogram for preoperative estimation risk of cervical lymph node metastasis in medullary thyroid carcinoma
por: Luo, Zhiyan, et al.
Publicado: (2022)